PTC Inc. (PTC) is trading down at $193.64 (-0.16%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Information Technology sector.
One firm's current price target on PTC Inc.: $205 — 6% above the current $194. Each is tracked to its date and scored the same way a member's call is.
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2016Sep 2016 | FY2017Sep 2017 | FY2018Sep 2018 | FY2019Sep 2019 | FY2020Sep 2020 | FY2021Sep 2021 | FY2022Sep 2022 | FY2023Sep 2023 | FY2024Sep 2024 | FY2025Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.14B | $1.16B | $1.24B | $1.26B | $1.46B | $1.81B | $1.93B | $2.10B | $2.30B | $2.74B |
| Growth (year over year) | −9.1% | +2.1% | +6.7% | +1.1% | +16.1% | +23.9% | +7.0% | +8.5% | +9.6% | +19.2% |
| Gross profit | $814.9M | $835.5M | $915.3M | $930.3M | $1.12B | $1.44B | $1.55B | $1.66B | $1.85B | $2.29B |
| Gross margin | 71.4% | 71.8% | 73.7% | 74.1% | 77.1% | 79.5% | 80.0% | 79.0% | 80.6% | 83.8% |
| Operating income | −$37.0M | $41.8M | $72.6M | $63.0M | $210.9M | $380.7M | $447.4M | $458.5M | $588.1M | $982.4M |
| Operating margin | −3.2% | 3.6% | 5.8% | 5.0% | 14.5% | 21.1% | 23.1% | 21.9% | 25.6% | 35.9% |
| Net income | −$54.5M | $6.24M | $52.0M | −$27.5M | $130.7M | $476.9M | $313.1M | $245.5M | $376.3M | $734.0M |
| Net margin | −4.8% | 0.5% | 4.2% | −2.2% | 9.0% | 26.4% | 16.2% | 11.7% | 16.4% | 26.8% |
| EPS (diluted) | −$0.48 | $0.05 | $0.44 | −$0.23 | $1.12 | $4.03 | $2.65 | $2.06 | $3.12 | $6.08 |
| Balance sheet | ||||||||||
| Cash and equivalents | $277.9M | $280.0M | $259.9M | $269.6M | $275.5M | $326.5M | $272.2M | $288.1M | $265.8M | $184.4M |
| Total assets | $2.35B | $2.36B | $2.33B | $2.66B | $3.38B | $4.51B | $4.69B | $6.29B | $6.38B | $6.62B |
| Total liabilities | $1.50B | $1.47B | $1.45B | $1.46B | $1.94B | $2.47B | $2.39B | $3.61B | $3.17B | $2.79B |
| Long-term debt | — | — | $643.3M | $669.1M | $1.01B | $1.44B | $1.35B | $1.69B | $1.23B | $1.17B |
| Shareholders' equity | $842.7M | $885.4M | $874.6M | $1.20B | $1.44B | $2.04B | $2.30B | $2.68B | $3.21B | $3.83B |
| Cash flow | ||||||||||
| Operating cash flow | $183.3M | $135.2M | $247.8M | $285.1M | $233.8M | $368.8M | $435.3M | $610.9M | $750.0M | $867.7M |
| Capital expenditure | $26.2M | $25.4M | $36.0M | $64.4M | $20.2M | $24.7M | $19.5M | $23.8M | $14.4M | $11.0M |
| Free cash flow | $157.1M | $109.8M | $211.7M | $220.7M | $213.6M | $344.1M | $415.8M | $587.0M | $735.6M | $856.7M |
| Share buybacks | $0 | $51.0M | $1.10B | $115.0M | $0 | $30.0M | $125.0M | $0 | $0 | $300.0M |
| Q4 FY24†Sep 2024 | Q1 FY25Dec 2024 | Q2 FY25Mar 2025 | Q3 FY25Jun 2025 | Q4 FY25†Sep 2025 | Q1 FY26Dec 2025 | Q2 FY26Mar 2026 | Q3 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $626.5M | $565.1M | $636.4M | $643.9M | $893.8M | $685.8M | $774.3M | $600.0M |
| Growth (year over year) | +14.6% | +2.7% | +5.5% | +24.2% | +42.7% | +21.4% | +21.7% | −6.8% |
| Gross profit | $513.7M | $453.3M | $530.1M | $533.9M | $776.9M | $568.1M | $660.7M | $490.5M |
| Gross margin | 82.0% | 80.2% | 83.3% | 82.9% | 86.9% | 82.8% | 85.3% | 81.7% |
| Operating income | $194.0M | $115.5M | $223.5M | $209.8M | $433.6M | $221.1M | $295.8M | $166.5M |
| Operating margin | 31.0% | 20.4% | 35.1% | 32.6% | 48.5% | 32.2% | 38.2% | 27.7% |
| Net income | $126.5M | $82.2M | $162.6M | $141.3M | $347.8M | $166.5M | $590.7M | $118.8M |
| Net margin | 20.2% | 14.6% | 25.6% | 21.9% | 38.9% | 24.3% | 76.3% | 19.8% |
| EPS (diluted) | $1.05 | $0.68 | $1.35 | $1.17 | $2.88 | $1.39 | $4.98 | $1.03 |
| Balance sheet | ||||||||
| Cash and equivalents | $265.8M | $196.3M | $235.2M | $199.3M | $184.4M | $209.7M | $439.1M | $351.5M |
| Total assets | $6.38B | $6.08B | $6.16B | $6.23B | $6.62B | $6.43B | $6.54B | $6.51B |
| Total liabilities | $3.17B | $2.85B | $2.78B | $2.72B | $2.79B | $2.58B | $2.68B | $3.04B |
| Long-term debt | $1.23B | $1.02B | $1.36B | $1.21B | $1.17B | $1.17B | $1.17B | $1.40B |
| Shareholders' equity | $3.21B | $3.23B | $3.39B | $3.51B | $3.83B | $3.84B | $3.86B | $3.47B |
| Cash flow | ||||||||
| Operating cash flow | $98.1M | $238.4M | $281.3M | $243.9M | $104.0M | $269.7M | $320.9M | $260.6M |
| Capital expenditure | $4.54M | $2.77M | $2.81M | $1.89M | $3.55M | $2.34M | $2.67M | $11.3M |
| Free cash flow | $93.6M | $235.7M | $278.5M | $242.0M | $100.5M | $267.4M | $318.2M | $249.3M |
| Share buybacks | $0 | $75.0M | $75.0M | $75.0M | $75.0M | $200.0M | $626.1M | $500.0M |
From PTC Inc.'s 10-K and 10-Q filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
PTC Inc. is an American computer software and services company founded in 1985 and headquartered in Boston, Massachusetts. The company was a pioneer in parametric, associative feature-based, solid computer-aided design (CAD) modeling software in 1988, including an Internet-based product for Product Lifecycle Management (PLM) in 1998. PTC markets products and services and an Internet of Things (IoT) and augmented reality (AR) platform for partners and developers.
PTC Therapeutics CLO Mark Boulding sells $12,337 in stock
PTC Therapeutics CLO Mark Boulding sells $12,337 in stock
PTC Therapeutics director Michael Schmertzler sells $158k in shares
PTC Therapeutics director Michael Schmertzler sells $158k in shares
PTC Therapeutics CLO Mark Boulding sells $132,790 in shares
PTC Therapeutics CLO Mark Boulding sells $132,790 in shares
RBC Capital reiterates PTC Therapeutics stock rating at Sector Perform
RBC Capital reiterates PTC Therapeutics stock rating at Sector Perform
PTC director Corinna Lathan sells $342,562 in stock
PTC director Corinna Lathan sells $342,562 in stock
Schneider Electric slides as J.P. Morgan sees PTC deal weighing on valuation
Schneider Electric slides as J.P. Morgan sees PTC deal weighing on valuation
BMO downgrades PTC stock rating on Schneider Electric deal
BMO downgrades PTC stock rating on Schneider Electric deal
Schneider Electric shares tumble 7% on $22.6 bln PTC deal
Schneider Electric shares tumble 7% on $22.6 bln PTC deal